SV7 Impact Medicine Fund LP - Insider Trading & Ownership

Entity
Company
Location
71 Kingsway, London, United Kingdom
Summary
The estimated value of insider holdings of SV7 Impact Medicine Fund LP is at least $2.68M dollars as of November 3, 2021. SV7 Impact Medicine Fund LP is the 10%+ Owner of Xilio Therapeutics, Inc. and owns shares of Xilio Therapeutics, Inc. (XLO) stock worth about $2.68M.
All Insider Reports
All Insider Reports

Ownership of SV7 Impact Medicine Fund LP

Insider Transactions Reported by SV7 Impact Medicine Fund LP:

* An asterisk sign (*) next to the price indicates that the price is likely invalid.